[1]
|
Cereal-based fermented foods as microbiota-directed products for improved child nutrition and health in sub-Saharan Africa
Critical Reviews in Food Science and Nutrition,
2024
DOI:10.1080/10408398.2024.2365342
|
|
|
[2]
|
Delivery of B. subtilis into Animal Intestine Using Chitosan-Derived Bioresorbable Gel Carrier: Preliminary Results
Gels,
2023
DOI:10.3390/gels9020120
|
|
|
[3]
|
Acute physiological effects following Bacillus subtilis DE111 oral ingestion – a randomised, double blinded, placebo-controlled study
Beneficial Microbes,
2023
DOI:10.3920/BM2022.0081
|
|
|
[4]
|
In vitro and in silico assessment of probiotic and functional properties of Bacillus subtilis DE111®
Frontiers in Microbiology,
2023
DOI:10.3389/fmicb.2022.1101144
|
|
|
[5]
|
The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial
Gut Microbes,
2022
DOI:10.1080/19490976.2022.2122668
|
|
|
[6]
|
The probiotic
Bacillus subtilis
BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial
Gut Microbes,
2022
DOI:10.1080/19490976.2022.2122668
|
|
|
[7]
|
The probiotic Bacillus subtilis BS50 decreases gastrointestinal symptoms in healthy adults: a randomized, double-blind, placebo-controlled trial
Gut Microbes,
2022
DOI:10.1080/19490976.2022.2122668
|
|
|
[8]
|
Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic Bacillus subtilis DE111
International Journal of Molecular Sciences,
2021
DOI:10.3390/ijms22052453
|
|
|
[9]
|
Presence and Germination of the Probiotic Bacillus subtilis DE111® in the Human Small Intestinal Tract: A Randomized, Crossover, Double-Blind, and Placebo-Controlled Study
Frontiers in Microbiology,
2021
DOI:10.3389/fmicb.2021.715863
|
|
|